nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey
|
Maki, Kevin C. |
|
2006 |
22 |
Supplement C |
p. 315-322 8 p. |
artikel |
2 |
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: The CCS-SAF Scale
|
Dorian, Paul |
|
2006 |
22 |
Supplement C |
p. 383-386 4 p. |
artikel |
3 |
Brucella endocarditis in prosthetic valves
|
Dahouk, Sascha Al. |
|
2006 |
22 |
Supplement C |
p. 971-974 4 p. |
artikel |
4 |
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management
|
Arnold, J. Malcolm O. |
|
2006 |
22 |
Supplement C |
p. 23-45 23 p. |
artikel |
5 |
Canadian Cardiovascular Society position statement – Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease
|
McPherson, Ruth |
|
2006 |
22 |
Supplement C |
p. 913-927 15 p. |
artikel |
6 |
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment
|
Buller, Christopher E. |
|
2006 |
22 |
Supplement C |
p. 511-515 5 p. |
artikel |
7 |
Changing outcomes of coronary revascularization in British Columbia, 1995–2001
|
Pate, Gordon E. |
|
2006 |
22 |
Supplement C |
p. 1197-1203 7 p. |
artikel |
8 |
Clinical prognosis, pre-existing conditions and the use of reperfusion therapy for patients with ST segment elevation acute myocardial infarction
|
Parker, Andrea B. |
|
2006 |
22 |
Supplement C |
p. 131-139 9 p. |
artikel |
9 |
Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease
|
Genest, Jacques |
|
2006 |
22 |
Supplement C |
p. 863-868 6 p. |
artikel |
10 |
Complement activity and pharmacological inhibition in cardiovascular disease
|
Théroux, Pierre |
|
2006 |
22 |
Supplement C |
p. 18B-24B nvt p. |
artikel |
11 |
Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand
|
Liang, Kae-Woei |
|
2006 |
22 |
Supplement C |
p. 691-696 6 p. |
artikel |
12 |
Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study – the Ezetrol® Add-On Study
|
Bissonnette, Stéphane |
|
2006 |
22 |
Supplement C |
p. 1035-1044 10 p. |
artikel |
13 |
Genetic determinants of vascular remodelling
|
Berk, Bradford C. |
|
2006 |
22 |
Supplement C |
p. 6B-11B nvt p. |
artikel |
14 |
ICD-10-CA/CCI coding algorithms for defining clinical variables to assess outcome after aortic and mitral valve replacement surgery
|
Quan, Hude |
|
2006 |
22 |
Supplement C |
p. 153-154 2 p. |
artikel |
15 |
Identifying which patients with diabetes should be tested for the presence of coronary artery disease – The importance of baseline electrocardiogram and exercise testing
|
Poirier, Paul |
|
2006 |
22 |
Supplement C |
p. 9A-15A nvt p. |
artikel |
16 |
Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral regurgitation
|
Wong, Graham C. |
|
2006 |
22 |
Supplement C |
p. 125-129 5 p. |
artikel |
17 |
Lower is better: Implications of the Treating to New Targets (TNT) study for Canadian patients
|
Fitchett, David H. |
|
2006 |
22 |
Supplement C |
p. 835-839 5 p. |
artikel |
18 |
Metabolic syndrome: A marker of patients at high cardiovascular risk
|
Lau, David C.W. |
|
2006 |
22 |
Supplement C |
p. 85B-90B nvt p. |
artikel |
19 |
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction
|
Ezekowitz, Justin A. |
|
2006 |
22 |
Supplement C |
p. 393-397 5 p. |
artikel |
20 |
Off-pump coronary artery bypass graft surgery is standard of care: Where do you stand?
|
Légaré, Jean-Francois |
|
2006 |
22 |
Supplement C |
p. 1107-1110 4 p. |
artikel |
21 |
Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: Experience from the PRAGUE studies
|
Widimsky, P. |
|
2006 |
22 |
Supplement C |
p. 1147-1152 6 p. |
artikel |
22 |
Prevention challenges: The era of atherosclerosis regression
|
Tardif, Jean-Claude |
|
2006 |
22 |
Supplement C |
p. 27C-30C nvt p. |
artikel |
23 |
PROVE-IT proved it: Lower is better – Pro
|
Leiter, Lawrence A. |
|
2006 |
22 |
Supplement C |
p. 91B-94B nvt p. |
artikel |
24 |
PROVE-IT proves that lower is better: A contrary view
|
Grover, Steven A. |
|
2006 |
22 |
Supplement C |
p. 95B-96B nvt p. |
artikel |
25 |
Q fever endocarditis: A case report and review of the literature
|
Deyell, Marc W. |
|
2006 |
22 |
Supplement C |
p. 781-785 5 p. |
artikel |
26 |
Surveillance and treatment of dyslipidemia in the post-infarct patient: Can a nurse-led management approach make a difference?
|
Lapointe, Francine |
|
2006 |
22 |
Supplement C |
p. 761-767 7 p. |
artikel |
27 |
The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic
|
Pearson, Glen J. |
|
2006 |
22 |
Supplement C |
p. 939-945 7 p. |
artikel |
28 |
The heart failure challenge: Optimizing medical and surgical management
|
Racine, Normand |
|
2006 |
22 |
Supplement C |
p. 8C-12C nvt p. |
artikel |
29 |
The value of lowering blood pressure
|
LeLorier, Jacques |
|
2006 |
22 |
Supplement C |
p. 63-64 2 p. |
artikel |
30 |
Treating the right patient at the right time: Access to echocardiography in Canada
|
Munt, B. |
|
2006 |
22 |
Supplement C |
p. 1029-1033 5 p. |
artikel |